THE TGA has published the
fourth edition of its Medicines
Safety Update on its website.
The new edition features an
update on Varenicline (Champix)
and including product summary
information, psychiatric symptoms
reported with varenicline and what
to include in an varenicline a
adverse reaction report.
The Medicines Safety Update
also includes a report on the
Australian experience with nonadjuvant
H1N1 vaccine (Panvax
and Panvax Junior), as well as
information on the new TGA
structural arrangements.
The Update also features details
on what to report.
To view a copy of the Safety
Update see www.tga.gov.au.The above article was sent to subscribers in Pharmacy Daily's issue from 03 Aug 10 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 03 Aug 10
MAYNE Pharma Group Limited has filed a patent infringement suit against Sun Pharmaceutical Industries Ltd and Inc., in the United States District Court, according to yesterday’s ASX announcement.
PHARMACY Connect 2024 conference will feature a provocative ‘Great Debate’ during the Harm Minimisation Workshop on Thu 05 Sep at the Hyatt Regency in Sydney.
LTR Pharma Limited has successfully raised $10.5 million through a share placement to sophisticated and new institutional investors, significantly surpassing initial demand.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.